Recently, a cellular mini-immune system comprising infinitely expandable dendritic cells and T cells led to the discovery that histamine receptor H1 antagonists act on T cells to stimulate their proliferation and polarization toward a Th1/Tc1 phenotype and to increase their anticancer activity in the context of immunochemotherapy.
Keywords: cancer; cell death; immunotherapy.
© 2023 The Author(s). Published with license by Taylor & Francis Group, LLC.